Regulators in Asia are weighing approval for COVID-19 vaccines developed by Pfizer Inc with partner BioNTech SE, Moderna Inc and AstraZeneca Plc, but few nations expect to get significant supplies initially.
Here are details of estimated distribution timelines, announced supply deals and clinical trials in the region.
SINGAPORE
On Dec. 30, the city-state became the first Asian country to begin inoculation of the Pfizer vaccine, despite one of the lowest fatality rates from the coronavirus worldwide.
It has signed advanced purchase pacts and made early down-payments on vaccines from Pfizer, Moderna and China's Sinovac Biotech Ltd.
It expects to have secured enough vaccines for its 5.7 million people by the third quarter of 2021.
AUSTRALIA
The country has secured about 140 million doses: 53.8 million from AstraZeneca, 51 million from Novavax Inc, 10 million from Pfizer, and 25.5 million from distribution programme COVAX.
It expects delivery of 3.8 million doses of AstraZeneca's vaccine in January and February 2021, and plans to begin inoculations in February.
NEW ZEALAND
Novavax agreed to supply 10.7 million doses, with initial doses to be delivered by mid-2021.
CHINA
China has not announced supply deals with Western drugmakers, which have partnered with private firms in the country instead.
AstraZeneca's vaccine may be approved in China by mid-2021 and is being produced by its Chinese partner Shenzhen Kangtai Biological Products Co Ltd.
Additionally, Shanghai Fosun Pharmaceutical Group Co Ltd plans to buy at least 100 million doses of the Pfizer/BioNTech vaccine.
Tibet Rhodiola Pharmaceutical Holding Co is bringing in Russian vaccine candidate Sputnik V and plans early and mid-stage trials in China.
On Dec. 31, China gave its first COVID-19 vaccine approval to a shot developed by a unit of state-backed Sinopharm, for use by the general public.
Prior to the approval, China had already vaccinated more than 2 million people under an emergency use programme, using three different shots developed by Sinopharm units and Sinovac.
JAPAN
Japan has deals to buy 120 million doses from Pfizer/BioNTech in the first half of 2021 and to purchase 120 million from AstraZeneca - the first 30 million to be shipped by March 2021. It has also agreed to buy 250 million from Novavax.
Japan is also in talks with Johnson & Johnson, and has a deal with Shionogi & Co Ltd.
Experts said vaccine makers would need to run at least Phase I and II trials in Japan before seeking approval for use.
SOUTH KOREA
The country has deals to buy 20 million doses each from AstraZeneca and Pfizer, 40 million from Moderna and 4 million doses from Johnson & Johnson's Janssen.
It will procure additional doses for 10 million people through COVAX, and its total supply deals will be enough to cover up to 56 million people.
Inoculation will begin in late February with the AstraZeneca vaccine.
INDIA
In January, India approved two COVID-19 vaccines for emergency use, one developed by AstraZeneca, and the other backed by a state-run institute.
It plans to roll out a vaccination programme by next week, aiming to cover 300 million people by July.
TAIWAN
Taiwan has agreed to buy almost 20 million doses of COVID-19 vaccine, including 10 million from AstraZeneca. It plans to get a total of 30 million vaccine doses to cover about 65% of its population.
The first vaccines are expected to arrive in March.
THAILAND
Thailand has secured 63 million doses of COVID-19 vaccine -- 61 million from AstraZeneca and 2 million from Sinovac.
The country will receive its first delivery of the AstraZeneca vaccine ahead of schedule before the second quarter, the government said.
MALAYSIA
The Southeast Asian nation has agreed to buy 12.8 million doses of the Pfizer vaccine and is in talks with the firm and others including Moderna, J&J, Sinovac and Russia's Gamaleya Institute to secure more to cover 83% of its population.
Pfizer will deliver the first batch of 1 million doses in the first quarter of 2021.
THE PHILIPPINES
The archipelago has signed only one supply deal, with the help of the private sector, to acquire 2.6 million doses of the AstraZeneca vaccine.
It is in talks with seven vaccine makers -- Novavax, Moderna, AstraZeneca, Pfizer, Sinovac, Johnson & Johnson and Russia's Gamaleya Institute-- to procure at least 148 million doses to inoculate close to two thirds of its population this year.
INDONESIA
Southeast Asia's most populous nation has secured 125.5 million doses from Sinovac, 30 million from Novavax and is in talks with AstraZeneca and Pfizer to buy 50 million doses each. It also expects to get 16 million from COVAX.
Indonesia is testing Sinovac's vaccine and preparing to start mass vaccination of medical staff and other frontline workers on Jan. 13.
VIETNAM
Vietnam has a deal to buy 30 million doses from AstraZeneca and in talks to purchase vaccines from Pfizer, Russia and China.
BANGLADESH
Bangladesh signed a deal with India's Serum Institute to buy 30 million doses of the AstraZeneca vaccine.
It also expects to receive 68 million doses from global vaccine alliance GAVI at a subsidised rate, a senior health ministry official said.
Reuters
Thu Jan 07 2021
Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" are seen in front of displayed pound banknotes with Queen Elizabeth and masks in this illustration taken October 31, 2020. REUTERS Pic
Battle Of The Reds: Legenda Liverpool masih bertenaga
Legenda Manchester United terpaksa akur dengan kekalahan kepada legenda Liverpool dengan jaringan 4-2.
Boling Padang: Farah Ain muncul juara dunia!
Farah pamer aksi luar biasa dalam penampilan sulungnya di pentas bertaraf dunia dengan kemenangan straight sets 6-2 dan 6-3.
Sultan Nazrin, Tuanku Zara hadiri majlis Aidilfitri PDRM Perak
Sultan dan Raja Permaisuri Perak berkenan berangkat menghadiri Majlis Sambutan Aidilfitri PDRM Kontinjen Perak 2024.
Nahas helikopter Lumut: Kebajikan, pendidikan anak-anak wira dipastikan tidak terabai - Menteri
Kementerian Pendidikan lakukan susur tindak bagi memastikan kebajikan 10 orang anak mangsa nahas helikopter dijaga sehingga tamat persekolahan kelak.
Bintang TikTok Iraq, Umm Fahad ditembak mati di luar rumah
Pihak berkuasa Iraq umum penubuhan "jawatankuasa siasatan khas- untuk menjejaki pembunuh yang tidak dikenali itu.
PM Anwar tiba di Riyadh untuk hadiri Mesyuarat Khas Forum Ekonomi Sedunia
Perdana Menteri Anwar tiba di Riyadh dalam rangka lawatan tiga hari bagi menghadiri Mesyuarat Khas Forum Ekonomi Sedunia (WEF).
Jemputan peribadi ke Mesyuarat Khas WEF bukti keakraban Putera Mahkota Mohammed, PM
Ini merupakan lawatan keempat Anwar ke Arab Saudi sejak dilantik sebagai Perdana Menteri.
Kerajaan Pusat peruntuk RM1.59 bilion untuk pembangunan fizikal di Terengganu
Peruntukan tersebut melibatkan 99 projek baharu dan 296 projek sambungan di bawah Rolling Plan 4 (RP4) Rancangan Malaysia ke-12 (RMK12).
Pahang rancang wujudkan zon perindustrian di setiap daerah
Kerajaan Pahang rancang wujudkan zon perindustrian di kesemua 11 daerah di negeri ini bagi menggalakkan kemasukan lebih banyak pelaburan asing khususnya dari China.
Kertas kabinet wujud sektor sukan dibentang dalam tempoh sebulan - Hannah
Hannah berkata dengan data yang lebih menyeluruh melibatkan sektor industri sukan nanti, pihaknya akan mampu merangsang pertumbuhan sukan di negara ini dengan lebih baik.
Kelaparan akut jejaskan 281.6 juta orang tahun lepas - PBB
Tahap bahaya kelaparan akut menjejaskan 281.6 juta orang tahun lepas, tahun kelima berturut-turut bahawa ketakjaminan makanan semakin memburuk.
Hamilton optimis kedudukan lebih baik di GP China
Lewis Hamilton melihat potensi kedudukan yang lebih baik dalam saingan Grand Prix yang kembali ke China buat pertama kali dalam tempoh lima tahun, hujung minggu ini.
'Selfish!' - Fasha Sandha sedih raya di Perlis tak jadi gara-gara dijangkiti COVID-19
Fasha berkata dia mula melakukan pemeriksaan COVID-19 selepas berasa tidak sihat badan dan mengalami bersin tidak henti sejak Raya pertama.
Kes COVID-19 catat penurunan ketara pada ME 14/2024 - KKM
Jumlah kes COVID-19 menurun 97.1 peratus kepada 493 kes pada Minggu Epidemiologi ke-14 (ME 14/2024) iaitu bagi tempoh 31 Mac hingga 6 April lepas berbanding 17,256 kes pada ME 1/2024.
China jadikan pengalaman pencegahan COVID-19 untuk hadapi pandemik masa depan
China akan menjadikan pengalaman dalam pencegahan dan kawalan COVID-19 untuk membuat persediaan yang lebih proaktif untuk menghadapi pandemik masa depan seperti "Penyakit X".
Negara berdepan ketirisan subsidi diesel serius - Amir Hamzah
Negara kini sedang berdepan isu ketirisan subsidi diesel yang serius dan wujud kemungkinan terdapat pihak yang tidak layak masih menikmati subsidi itu, kata Menteri Kewangan II Datuk Seri Amir Hamzah.
Kematian akibat kemalangan jalan raya lebih tinggi daripada COVID-19 - Anthony Loke
PDRM akan mengeluarkan data mengenai kemalangan jalan raya pada setiap hari, bukan setahun sekali seperti diamalkan sebelum ini.
Ismail Sabri ziarah lapan beradik yatim piatu akibat COVID-19
Ismail Sabri tiba kira-kira jam 2 petang di kediaman lapan beradik itu di Taman Adenium, Bukit Beruntung pada Selasa.
Teori konspirasi 'Penyakit X'
Ahli teori konspirasi AS sekali lagi membuat 'keuntungan' selepas PBB memberi amaran tentang wabak lebih berbahaya iaitu 'Penyakit X'.
Reformasi dasar, kukuhkan perlindungan, produktiviti pekerja tidak formal
Reformasi dasar perlu dilakukan dalam usaha meningkatkan perlindungan dan produktiviti pekerja tidak formal di Malaysia.